Academic freedom in clinical research.
Nathan
David G
DG
Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Weatherall
David J
DJ
D002170:Canada; D003219:Confidentiality / Q000266:history; D016265:Conflict of Interest; D000077543:Deferiprone; D004345:Drug Industry / Q000266:history*; D004989:Ethics / Q000266:history*; D005610:Freedom; D049673:History, 20th Century; D006776:Hospitals, Pediatric / Q000266:history; D006801:Humans; D007373:Interinstitutional Relations; D007502:Iron Chelating Agents / Q000009:adverse effects / Q000266:history* / Q000627:therapeutic use; D019190:Iron Overload / Q000188:drug therapy / Q000266:history; D009864:Ontario; D011643:Publishing / Q000266:history* / Q000331:legislation & jurisprudence; D011728:Pyridones / Q000009:adverse effects / Q000266:history* / Q000627:therapeutic use; D012109:Research Support as Topic / Q000266:history*; D017211:Treatment Failure; D014495:Universities / Q000266:history*
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone